This approach minimizes repeated freeze-thaw cycles on the primary stock solution while maintaining convenient access to working concentrations
Limitations of Use: The use of VYVANSE is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.5), Use in Specific Populations (8.4)]
Garber AJ, Larsen J, Schneider SH, Piper BA, Henry D
It is not approved for adolescents
If you are consistently below this at 5mg for several months, this would typically prompt a conversation about whether moving to 7.5mg is appropriate
Yael Weiss built Mahzi Therapeutics to break that rule